Zacks Research Issues Optimistic Forecast for GSK Earnings
GSK plc (NYSE:GSK – Free Report) – Equities research analysts at Zacks Research increased their FY2025 earnings estimates for GSK in a research report issued to clients and investors on Wednesday, February 26th. Zacks Research analyst E. Bagri now anticipates that the pharmaceutical company will earn $4.14 per share for the year, up from their […]
